Efficacy rates of corona vaccines against the Indian variant have been announced.

class = “cf”>

The Public Health Agency of England (PHE) examined the effects of Kovid-19 vaccines in 1,054 cases in which the Indian variant, named B.1.617.2, was registered from April 5 to May 15.

As a result, 2 weeks after administration of the second dose, the Pfizer-BioNTech vaccine was 88% effective in preventing symptoms caused by the Indian variant, and the Oxford-AstraZeneca vaccine was 66% effective.

The efficacy rate of the two vaccines against the Indian variant fell to 33% 3 weeks after the administration of the first dose.

Health Minister Mart Hancock noted that the research results proved that the Kovid-19 vaccination program they had implemented was effective in saving lives.

Hancock said that more than 20 million people vaccinated in the country are also protected against the Indian variant, and that it is important to have the second dose of the vaccine to protect against the new variants.

Mary Ramsay, head of the PHE vaccination unit, noted that administering two doses of both vaccines provides assurance of protection against the Indian variant.

class = “cf”>

Ramsay said they expected the Kovid-19 vaccines to be even more effective in preventing hospitalizations and deaths, and that it is “vital” to have both doses of the vaccine in order to provide a level high protection against all existing or future variants.

While the number of people who received the first dose of the Kovid-19 vaccine in England increased to 37 million 726,000 924, the second dose was applied to 22 million 71,000 497 of them.

In the country, it is estimated that with the Kovid-19 vaccination program, which began on December 8, 13,000 deaths over the age of 60 and the hospitalization of more than 30,000 people were prevented.

Bigpara for cryptocurrency markets

Bigpara for cryptocurrency markets

Add a Comment